SODIUM VALPROATE JUNO sodium valproate 400 mg/4mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate juno sodium valproate 400 mg/4ml solution for injection, ampoule

juno pharmaceuticals pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: water for injections - sodium valproate juno is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE SANDOZ sodium valproate 500mg enteric coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate sandoz sodium valproate 500mg enteric coated tablet blister pack

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: hyprolose; calcium silicate; amaranth aluminium lake; titanium dioxide; polyvinyl acetate phthalate; diethyl phthalate; stearic acid; purified talc; povidone; hypromellose; magnesium stearate; macrogol 6000; indigo carmine aluminium lake; citric acid monohydrate - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

SODIUM VALPROATE SANDOZ sodium valproate 200mg enteric coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate sandoz sodium valproate 200mg enteric coated tablet blister pack

sanofi-aventis australia pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; polyvinyl acetate phthalate; indigo carmine aluminium lake; hyprolose; magnesium stearate; povidone; stearic acid; amaranth aluminium lake; diethyl phthalate; purified talc; macrogol 6000; calcium silicate; hypromellose; titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

METAMIZOLE SODIUM powder United States - English - NLM (National Library of Medicine)

metamizole sodium powder

american pharmaceutical ingredients llc - metamizole sodium (unii: vsu62z74on) (metamizole sodium - unii:vsu62z74on) -

METAMIZOLE SODIUM powder United States - English - NLM (National Library of Medicine)

metamizole sodium powder

professional group of pharmacists new york llc - metamizole sodium (unii: vsu62z74on) (metamizole - unii:934t64rmnj) -

AX PHARMACEUTICAL CORP- metamizole sodium powder United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp- metamizole sodium powder

ax pharmaceutical corp - metamizole sodium (unii: vsu62z74on) (metamizole - unii:934t64rmnj) - metamizole 495 g in 500 g

VALPREASE 500 sodium valproate 500 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valprease 500 sodium valproate 500 mg tablet blister pack

arrotex pharmaceuticals pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: triethyl citrate; citric acid; magnesium stearate; sodium starch glycollate; purified talc; povidone; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; indigo carmine; sunset yellow fcf; allura red ac; macrogol 3350 - epilepsy. primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.. mania. for the treatment of mania where other therapy has proved inadequate or is inappropriate.

VALPREASE 200 sodium valproate 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valprease 200 sodium valproate 200 mg tablet blister pack

arrotex pharmaceuticals pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: purified talc; triethyl citrate; sodium starch glycollate; colloidal anhydrous silica; microcrystalline cellulose; povidone; magnesium stearate; citric acid; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; titanium dioxide; indigo carmine; sunset yellow fcf; allura red ac; polyvinyl alcohol; macrogol 3350; xanthan gum; lecithin - epilepsy. primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.. mania. for the treatment of mania where other therapy has proved inadequate or is inappropriate.